AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 14636346
Drug: Antiepileptic monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiepileptic monotherapy with prednisolone (1 mg/kg/day for 10 days, tapering over 4 days)
Trial: 14636346
Drug: Antiepileptic monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiepileptic monotherapy alone
Trial: 14636346
Drug: Antiepileptic monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiepileptic monotherapy with prednisolone
Trial: 10389804
Drug: IV droperidol
RxNorm normalized name: Droperidol
DrugBank: Droperidol (DB00450)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV droperidol 1.25 mg
Trial: 1676594
Drug: Vecuronium 0.08
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium 0.08 mg kg‐1
Trial: 6350090
Drug: Lorajmine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorajmine (600 mg/day)
Trial: 6350090
Drug: After therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: After therapy interruption
Trial: 2932514
Drug: Indomethacin (a
RxNorm normalized name: indomethacin (as indomethacin sodium trihydrate) 1 MG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (a cyclooxygenase inhibitor)
Trial: 2932514
Drug: Dazoxiben hydrochloride
RxNorm normalized name: Chlorpromazine Hydrochloride
DrugBank: Dazoxiben (DB03052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dazoxiben hydrochloride (a thromboxane synthase inhibitor)
Trial: 2932514
Drug: BM13.177 (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BM13.177 (a thromboxane receptor antagonist)
Trial: 27537992
Drug: CF101 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CF101 2 mg
Trial: 23918683
Drug: Hydrocortisone 30
RxNorm normalized name: hydrocortisone 30 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone 30 mg divided in 2 doses
Trial: 23918683
Drug: Hydrocortisone 30
RxNorm normalized name: hydrocortisone 30 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone 30 mg divided in 4 doses
Trial: 18726610
Drug: Vehicle eye
RxNorm normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle eye drop solution
Trial: 16029343
Drug: Levamisole 150
RxNorm normalized name: levamisole 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole 150 mg (or 100 mg for children)
Trial: 14500148
Drug: Spinal Anesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal Anesthesia (6 mg bupivacaine and 15 micro g fentanyl)
Trial: 14500148
Drug: Psoas Compartment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psoas Compartment Block (40 mL of 1.5% mepivacaine)
Trial: 1677910
Drug: Ficoll fractionated
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ficoll fractionated and Mafosfamide purged cells (50 micrograms/ml/1 x 10e7 MN cells)
Trial: 6406454
Drug: Bupropion (50-450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion (50-450 mg/day to 300-750 mg/day)
Trial: 6406454
Drug: Amitriptyline (75-225
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (75-225 mg/day)
Trial: 20137432
Drug: Social skills
RxNorm normalized name: Safety 1st Social Safety Pack KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social skills training program (1 hour weekly for 12 weeks)
Trial: 14769727
Drug: Emergency department
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emergency department treatment of COPD exacerbation
Trial: 11686543
Drug: Losartan (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (25 mg/day)
Trial: 9692119
Drug: Prednisolone 0.5
RxNorm normalized name: prednisoLONE 0.5 % Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone 0.5 mg kg-1
Trial: 9692119
Drug: Prednisolone 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone 1.0 mg kg-1
Trial: 9692119
Drug: Prednisolone 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone 2.0 mg kg-1
Trial: 7921938
Drug: Intravesical epirubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical epirubicin at a concentration of 1 mg/ml (n = 40)
Trial: 7921938
Drug: Intravesical epirubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical epirubicin at a concentration of 2 mg/ml (n = 41)
Trial: 2908134
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg bromazepam
Trial: 27838660
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg nicotine inhaler
Trial: 27838660
Drug: nicotine administration
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: nicotine administration
Trial: 24347903
Drug: Hybrid fractionation
RxNorm normalized name: Amaranthus hybridus pollen
DrugBank: Amaranthus hybridus pollen (DB15503)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid fractionation (6GyX3 fractions on alternate days during the 1st week, followed by 2GyX5 daily fractions in the 2nd week)
Trial: 24347903
Drug: Standard fractionation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard fractionation (3GyX5 daily fractions for 2 consecutive weeks)
Trial: 16473752
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (10 sessions over 2 weeks)
Trial: 10695943
Drug: Intraoral fluoride
RxNorm normalized name: Hydrogen fluoride
DrugBank: Hydrogen fluoride (DB11072)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoral fluoride releasing device (IFRD) consisting of sodium fluoride encased in an acrylic polymer, releasing fluoride at approximately 0.04 mg/day
Trial: 9085402
Drug: Buprenorphine (4,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (4, 8, 16 mg)
Trial: 9085402
Drug: Hydromorphone (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydromorphone (9 and 18 mg)
Trial: 8335191
Drug: Azathioprine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azathioprine (2.5 mg/kg body weight) combined with prednisolone (60 mg daily tapering to 10 mg)
Trial: 8335191
Drug: Prednisolone (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (60 mg daily tapering to 10 mg) monotherapy
Trial: 8335191
Drug: Azathioprine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azathioprine (2.5 mg/kg body weight) combined with prednisolone
Trial: 30049743
Drug: Prednisolone monotherapy
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone monotherapy
Trial: 24525661
Drug: Org 25935
RxNorm normalized name: ORG-25935
DrugBank: ORG-25935 (DB12220)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 25935 (4 to 8 mg twice daily)
Trial: 24525661
Drug: Org 25935
RxNorm normalized name: ORG-25935
DrugBank: ORG-25935 (DB12220)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 25935 (12 to 16 mg twice daily)
Trial: 20162706
Drug: Intravesical gemcitabine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical gemcitabine (2000 mg/50 mL) twice weekly for 6 weeks, then weekly for 3 weeks at 3, 6, and 12 months
Trial: 20162706
Drug: Intravesical BCG
RxNorm normalized name: BCG, live, Tice strain
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical BCG (Connaught strain, 81 mg/50 mL) over a 6-week induction course and weekly for 3 weeks at 3, 6, and 12 months
Trial: 15917336
Drug: Pentoxifylline (PTF)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (PTF) 1200 mg daily
Trial: 14699228
Drug: Pyridostigmine continued
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyridostigmine continued with morning dose on the day of surgery (Group 2)
Trial: 10805066
Drug: Gavestinel 800
RxNorm normalized name: Gavestinel
DrugBank: Gavestinel (DB06741)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gavestinel 800 mg loading dose followed by 100-, 200-, or 400-mg maintenance doses every 12 hours for five doses
Trial: 7963447
Drug: Dothiepin 75-150
RxNorm normalized name: dothiepin 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dothiepin 75-150 mg/day
Trial: 3308579
Drug: Buffy coat
RxNorm normalized name: Leucocyte buffy coat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buffy coat transfusions (approximately 0.6 X 10(9) T-lymphocytes) weekly for 5 weeks
Trial: 24763133
Drug: Vedolizumab 750
RxNorm normalized name: Vedolizumab
DrugBank: Vedolizumab (DB09033)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Vedolizumab 750 mg
Trial: 23865726
Drug: Fluticasone propionate/formoterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone propionate/formoterol (flutiform) 250/10 µg b.i.d.
Trial: 22352202
Drug: Lamotrigine (LTG)
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine (LTG) therapy added to NIAAA protocol for 2004
Trial: 19043252
Drug: Calcium channel
RxNorm normalized name: Calcium channel blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium channel blocker (CCB; amlodipine or nifedipine)
Trial: 2550642
Drug: Lisinopril 20
RxNorm normalized name: lisinopril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril 20 mg once daily with hydrochlorothiazide 25 mg
Trial: 2550642
Drug: Captopril 50
RxNorm normalized name: captopril 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 50 mg once daily with hydrochlorothiazide 25 mg
Trial: 16672214
Drug: Molocco+B12 tablets
RxNorm normalized name: Coenzyme B12
DrugBank: Cobamamide (DB11191)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Molocco+B12 tablets
Trial: 15610110
Drug: Vardenafil 10
RxNorm normalized name: vardenafil 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vardenafil 10 mg (with option to titrate to 5, 10, or 20 mg)
Trial: 11377409
Drug: Naltrexone (started
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone (started at 25 mg/day, titrated up to 250 mg/day)
Trial: 30406565
Drug: Anti-citrullinated α-enolase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-citrullinated α-enolase peptide 1 antibodies (a-CEP-1)
Trial: 30406565
Drug: Anti-mutated citrullinated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-mutated citrullinated vimentin antibodies (a-Sa)
Trial: 30406565
Drug: Anti-caramylated protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-caramylated protein antibodies (a-CarP)
Trial: 30406565
Drug: Anti-hnRNP/RA33 antibodies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-hnRNP/RA33 antibodies (a-hnRNP/RA33)
Trial: 30406565
Drug: Anti-filaggrin antibodies
RxNorm normalized name: Anti-VEGF monoclonal antibody
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Anti-filaggrin antibodies (AFAs)
Trial: 26632177
Drug: 0.5% Rice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% Rice Bran Supercritical CO2 Extract (RB-SCE) applied dermally (8 mL/d) for 16 weeks
Trial: 23277250
Drug: Iloperidone 8
RxNorm normalized name: iloperidone 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iloperidone 8 mg BID
Trial: 23277250
Drug: Iloperidone 12
RxNorm normalized name: iloperidone 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iloperidone 12 mg BID
Trial: 23277250
Drug: Iloperidone 24
RxNorm normalized name: Iloperidone
DrugBank: Iloperidone (DB04946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iloperidone 24 mg QD
Trial: 23277250
Drug: Quetiapine 375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine 375 mg BID
Trial: 23277250
Drug: Iloperidone with
RxNorm normalized name: Iloperidone
DrugBank: Iloperidone (DB04946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iloperidone with metabolic inhibitors (paroxetine and ketoconazole)
Trial: 10934078
Drug: Ciprofloxacin monotherapy
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin monotherapy with reevaluation at 3 days
Trial: 10934078
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (choice and duration of antibiotics at the discretion of physicians)
Trial: 10934078
Drug: Ciprofloxacin monotherapy
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin monotherapy
Trial: 8681595
Drug: Pentoxifylline (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (1.5 mg/kg/hr iv) for 5 days in trauma patients (n = 15)
Trial: 8681595
Drug: Pentoxifylline (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (1.5 mg/kg/hr iv) for 5 days in sepsis patients (n = 15)
Trial: 8681595
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution as placebo in trauma patients (n = 15)
Trial: 8681595
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution as placebo in sepsis patients (n = 15)
Trial: 1558329
Drug: mPEG modified
RxNorm normalized name: MPEG 6000 acetyl lysine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mPEG modified grass pollen mix allergen preparation (mPEG‐gm)
Trial: 1558329
Drug: Partly purified
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partly purified grass pollen mix allergen preparation (gm)
Trial: 1558329
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments at high dose levels (120,000 BU)
Trial: 6395323
Drug: tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: tranexamic acid (Cyklocapron, 4.5 g per day for 6 weeks)
Trial: 31433269
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (3000 mg/day, 1053 mg omega-3 fatty acids) plus wheat germ oil (300 mg/day, 0.765 mg vitamin E)
Trial: 11179277
Drug: Oral methionine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral methionine
Trial: 11179277
Drug: Oral homocysteine
RxNorm normalized name: mecysteine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral homocysteine
Trial: 2963746
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose (300 mg/day) medroxyprogesterone acetate
Trial: 2963746
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (1000 mg/day) medroxyprogesterone acetate
Trial: 28545189
Drug: Modified Triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified Triple Therapy (MTT): 20 mg omeprazole t.i.d., 500 mg amoxicillin t.i.d., and 500 mg clarithromycin b.i.d. for 14 days
Trial: 28545189
Drug: Standard Triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Triple Therapy (STT): 20 mg omeprazole b.i.d., 1000 mg amoxicillin b.i.d., and 500 mg clarithromycin b.i.d. for 14 days
Trial: 17878149
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid (5 mg yearly intravenous infusion)
Trial: 9129487
Drug: Psyllium (1.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psyllium (1.4 g/MJ)
Trial: 2885462
Drug: Intravenous methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous methylprednisolone for 7 days added to antibiotic regimen
Trial: 30246186
Drug: Immediately loaded
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediately loaded implants with a temporary resin fixed partial denture
Trial: 30246186
Drug: Conventionally loaded
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventionally loaded implants with definitive multi-unit abutments
Trial: 26949133
Drug: Control (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (standard treatment alone)
Trial: 26201510
Drug: Weekly supervised
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly supervised group sessions of progressive balance training for two years, supplemented by individually prescribed home exercises
Trial: 26201510
Drug: Weekly supervised
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly supervised group sessions of progressive balance training for two years
Trial: 18938022
Drug: Caries Check
RxNorm normalized name: Tilletia caries
DrugBank: Tilletia caries (DB10705)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caries Check (CC)
Trial: 16675163
Drug: Outreach Case
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Outreach Case Management (OCM) for 6 weeks, designed to motivate and coach patients to re-enter treatment.
Trial: 16675163
Drug: Passive Referral
RxNorm normalized name: teferrol
DrugBank: Iron polymaltose (DB15763)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Passive Referral (PR) for drug treatment, n=52.
Trial: 3729666
Drug: Naloxone hydrochloride
RxNorm normalized name: Naloxone Hydrochloride
DrugBank: Naloxone (DB01183)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naloxone hydrochloride 0.1 mg/kg
Trial: 3729666
Drug: Naloxone hydrochloride
RxNorm normalized name: Naloxone Hydrochloride
DrugBank: Naloxone (DB01183)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naloxone hydrochloride 2.0 mg/kg
Trial: 31643142
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (case manager and doctor)
Trial: 29105893
Drug: Conventional meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional meal (potato-cheese cream followed by vanilla cream)
Trial: 29105893
Drug: Unconventional meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unconventional meal (mixture of both creams)
Trial: 15932835
Drug: Bazedoxifene 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bazedoxifene 10 mg/d
Trial: 12796576
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg oxandrolone twice a day (n = 14)
Trial: 12796576
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg oxandrolone
Trial: 12634875
Drug: beta-blocker therapy
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: beta-blocker therapy (bisoprolol, carvedilol, metoprolol)
Trial: 6476789
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg dose of pyridoxine hydrochloride
Trial: 30379814
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of pentamidine isethionate (PI) 7 mg/kg
Trial: 30379814
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of pentamidine isethionate (PI) 7 mg/kg
Trial: 30379814
Drug: Three doses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three doses of pentamidine isethionate (PI) 7 mg/kg
Trial: 23514685
Drug: Conventional injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional injection technique
Trial: 17689509
Drug: Intracoronary BH4
RxNorm normalized name: 6R-BH4
DrugBank: Sapropterin (DB00360)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intracoronary BH4 (250 microg/min & 500 microg/min) co-administered with acetylcholine (Ach, 10(‐7) & 10(‐6) M)
Trial: 17689509
Drug: Intracoronary BH4
RxNorm normalized name: 6R-BH4
DrugBank: Sapropterin (DB00360)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intracoronary BH4 (500 microg/min) co-administered with acetylcholine (Ach, 10(‐7) & 10(‐6) M)
Trial: 17689509
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no BH4 treatment)
Trial: 16248952
Drug: Tumor vaccine
RxNorm normalized name: DNP-Modified autologous tumor vaccine
DrugBank: DNP-Modified autologous tumor vaccine (DB17436)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tumor vaccine (3 vaccinations at 2-week intervals, consisting of formalin-fixed HCC tissue fragments, biodegradable sustained-releasers of GM-CSF, IL-2, and an adjuvant)
Trial: 11895628
Drug: Threshold doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Threshold doses for allergenic foods
Trial: 7766742
Drug: Omeprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (40 mg mane), Amoxycillin (500 mg t.d.s.), Metronidazole (400 mg t.d.s.) for 14 days
Trial: 7766742
Drug: Omeprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (40 mg mane), Amoxycillin (500 mg t.d.s.), Metronidazole (400 mg t.d.s.) for 7 days
Trial: 7766742
Drug: Omeprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (40 mg mane), Amoxycillin (500 mg t.d.s.) for 7 days and Metronidazole for 5 days
Trial: 26899778
Drug: Lenalidomide (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenalidomide (25 mg orally on days 1-21 every 28 days)